Hansol Chemica (014680) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Hansol Chemica KRW 260,150, price KRW 236,500, upside +10.0%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Hansol Chemica for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 85,873 KRW – 353,034 KRW · fair‑value band 166,203 KRW – 344,732 KRW · the 236,500 KRW price screens below the 260,150 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Hansol Chemica in your weekly email
Every Wednesday you see whether Hansol Chemica is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hansol Chemical Co., Ltd., together with its subsidiaries, manufactures and sells various chemicals primarily in South Korea.
Show more
Hansol Chemical Co., Ltd., together with its subsidiaries, manufactures and sells various chemicals primarily in South Korea. The company offers a range of fine chemicals, including hydrogen peroxide, sodium hydrosulfite, benzoyl peroxide, HITEX SB latex, HANBL NB latex, HanSphere, flocculant, organic coagulant, retention agent, and fixing agents, as well as semiconductors comprising high-k, silicon, and electrode and metal precursors. It also provides display materials, such as quantum dots, a self-luminous nanoparticle; UV ink, a low-viscosity ink-jet resin; and functional UV resin. In addition, the company offers lithium-ion battery (LiB) materials, including anode binders, a product that bonds the anode active material and copper foil; separator binder; Si anode; and CNT dispersant. Hansol Chemical Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.
Stock analysis
Hansol Chemica (014680) currently trades at 236,500 KRW, while our model-based Fair Value estimate is 260,150 KRW, implying the stock looks roughly 9.1% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 217,037 KRW per share, and 2 of the 24 models we run sit above the 236,500 KRW price.
Bear case: the Asset-Based group reads lowest at 64,240 KRW, and 22 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: 166,203 KRW (bear) to 344,732 KRW (bull), the price of 236,500 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Hansol Chemica reported revenue of 884B KRW in FY2025 versus 769B KRW in FY2021, a compound +3.6%/yr. Reported net income was 147B KRW in FY2025, compounding −0.2%/yr from FY2021.
Key figures
Market cap 2.6T KRW (≈ $1.8B) · P/S ratio 2.85 · Dividend yield 1.1% · Net margin 16.7% · Return on equity 13.6% · Return on assets (EBIT) 11.8% · Operating margin 19.2% · Revenue (TTM) 906B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 30% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 2% fair-value upside, at 10%, 014680 screens cheaper than that median.
Fair Value models
Bear 166,203 KRWFair Value 260,150 KRWBull 344,732 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.77/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+13.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.4%
Start year 2020 (pandemic). Over 10 years: +9.2% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+5.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.1%
Dividend (yield on the price)1.1%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 18%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+12.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +17.1% a year for the price and +10.2% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 355 stocks
Beats the industry median on 9/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score65 · Top 25%
Fair Value upside+10% · Above median
Profitability
Return on equity (TTM)14% · Top 25%
Return on assets6% · Top 25%
Net margin (TTM)17% · Top 25%
Operating margin (TTM)19% · Top 25%
Growth and dividend
Revenue growth11% · Above median
Dividend yield (TTM)1.1% · Below median
Balance sheet
Debt / equity0.13× · Below median
Valuation Multiplesvs Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hansol Chemica Fair Value". https://www.fairvalue-calculator.com/stock/014680
Frequently asked questions
Is Hansol Chemica (014680) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 260,150 KRW versus a price of 236,500 KRW, about +10% upside (undervalued).
What is the fair value of 014680?
Our model-based fair value for Hansol Chemica is 260,150 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 236,500 KRW.
What is the quality score of 014680?
Hansol Chemica has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hansol Chemica (014680)?
Our model-based price target is the fair value of 260,150 KRW (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 166,203 KRW, optimistic scenario 344,732 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Hansol Chemica stock forecast for 2026?
Our models put fair value at 260,150 KRW, about +10% upside versus a price of 236,500 KRW (undervalued). Cautious scenario 166,203 KRW, optimistic scenario 344,732 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Hansol Chemica (014680)?
Hansol Chemica reported trailing-twelve-month revenue of about 906B KRW (latest available figure, as of Sep 24, 2026).
Does Hansol Chemica pay a dividend?
Hansol Chemica currently shows a dividend yield of about 1.10% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Hansol Chemica (014680)?
For today's price to be fair in a discounted-cash-flow model, Hansol Chemica would have to grow free cash flow by +19.5 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.4 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 014680 use?
Our models discount Hansol Chemica at 12.6 %: a base by market capitalisation (small), damped by beta 1.32, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Hansol Chemica that is +19.5 % per year a year over ten years, using the same discount rate (12.6 %) and the same formula as our fair value.
How much growth has Hansol Chemica (014680) delivered so far?
Over the past 5 years revenue at Hansol Chemica grew +7.4 % a year. The price currently implies +19.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Hansol Chemica (014680) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Hansol Chemica (+19.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Hansol Chemica (014680)?
The free-cash-flow yield on the price is 4.53 %: that much free cash flow Hansol Chemica produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Hansol Chemica (014680)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hansol Chemica it is 260,150 KRW per share (as of Sep 24, 2026), against a price of 236,500 KRW. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Hansol Chemica stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 014680 trades below its calculated fair value: price 236,500 KRW, fair value 260,150 KRW, a gap of about +10% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 014680?
No. The price is what the market pays today (236,500 KRW); the fair value is what the company's own numbers justify (260,150 KRW). For Hansol Chemica the two are 23,650 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Hansol Chemica worth?
The market values Hansol Chemica at about 2.6T KRW (market capitalisation, as of Sep 24, 2026). Per share that is 236,500 KRW; our models calculate a fair value of 260,150 KRW per share.
What do the bullish and bearish scenarios say about 014680?
Our models span a range for Hansol Chemica: cautious scenario 166,203 KRW, base 260,150 KRW, optimistic 344,732 KRW per share (as of Sep 24, 2026, price 236,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of 014680?
The PEG ratio of Hansol Chemica is 1.07 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Hansol Chemica (014680)?
Balance-sheet figures for Hansol Chemica (as of Sep 24, 2026): return on equity 13.6%, debt of 0.13 per unit of equity. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is 014680 from its 52-week high?
Hansol Chemica trades at 236,500 KRW, about 30% below its 52-week high of 336,000 KRW and 24% above the low of 190,700 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 260,150 KRW is for.
Which stocks are comparable to Hansol Chemica?
From the same area (Basic Materials) we also value BASF SE, Ningxia Baofeng Energy Group, Dow Inc, Zhejiang Juhua Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hansol Chemica stock attractive at the current price?
The data as of Sep 24, 2026: price 236,500 KRW, calculated fair value 260,150 KRW (+10%), Quality Score 65/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 014680 calculated?
We run Hansol Chemica through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 260,150 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Hansol Chemica currently trades 10 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hansol Chemica (014680)?
The closing price on Sep 23, 2026 was 236,500 KRW. Our model-based fair value is 260,150 KRW, about +10% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hansol Chemica right now?
A fairly wide model range (166,203 KRW to 344,732 KRW) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Hansol Chemica
How large is the market capitalisation of Hansol Chemica (014680)?
The market capitalisation of Hansol Chemica is 2.6T KRW (≈ $1.8B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hansol Chemica (014680)?
The price-to-sales ratio of Hansol Chemica is 2.85 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Hansol Chemica (014680)?
The dividend yield of Hansol Chemica is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hansol Chemica (014680)?
The net margin of Hansol Chemica is 16.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hansol Chemica (014680)?
The return on equity (ROE) of Hansol Chemica is 13.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hansol Chemica (014680)?
On an EBIT basis the return on assets of Hansol Chemica is 11.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hansol Chemica (014680)?
The operating margin of Hansol Chemica is 19.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hansol Chemica (014680)?
Revenue at Hansol Chemica is growing +10.6% versus a year earlier (3y avg −0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hansol Chemica (014680)?
Earnings per share at Hansol Chemica are growing +14.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Hansol Chemica (014680) carry?
The net debt of Hansol Chemica is 168B KRW (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Hansol Chemica in the live analysis
One click puts Hansol Chemica on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
